Matches in Wikidata for { <http://www.wikidata.org/entity/Q37672806> ?p ?o ?g. }
- Q37672806 description "article científic" @default.
- Q37672806 description "article scientifique" @default.
- Q37672806 description "articolo scientifico" @default.
- Q37672806 description "artigo científico" @default.
- Q37672806 description "artículu científicu espublizáu en 2008" @default.
- Q37672806 description "bilimsel makale" @default.
- Q37672806 description "scientific article published on February 2008" @default.
- Q37672806 description "vedecký článok" @default.
- Q37672806 description "vetenskaplig artikel" @default.
- Q37672806 description "videnskabelig artikel" @default.
- Q37672806 description "vědecký článek" @default.
- Q37672806 description "wetenschappelijk artikel" @default.
- Q37672806 description "wissenschaftlicher Artikel" @default.
- Q37672806 description "наукова стаття, опублікована в лютому 2008" @default.
- Q37672806 description "научни чланак" @default.
- Q37672806 description "مقالة علمية نشرت في فبراير 2008" @default.
- Q37672806 name "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 name "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 name "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 type Item @default.
- Q37672806 label "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 label "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 label "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 prefLabel "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 prefLabel "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 prefLabel "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 P1433 Q37672806-DC6D14AF-5254-4F32-92E8-D82EA1E9806A @default.
- Q37672806 P1476 Q37672806-069D3ED4-4045-4240-BD8E-5FE833A19F46 @default.
- Q37672806 P2093 Q37672806-3EF8A486-715B-4D5B-ADFE-666FC4FA49BB @default.
- Q37672806 P2093 Q37672806-49D62732-3452-4649-98FA-6E92A888FD9A @default.
- Q37672806 P2093 Q37672806-6DCCF22C-1EEA-46A2-8991-8BD59FD8F0C1 @default.
- Q37672806 P2093 Q37672806-96047F2D-F67B-46B3-972F-E62FAD1E973B @default.
- Q37672806 P2093 Q37672806-CD80C85D-7CEA-44D1-8ED1-5DC0D2E32FAD @default.
- Q37672806 P2093 Q37672806-DFCE2E52-9FAB-4BE4-ACB0-E1CA34F5FEB7 @default.
- Q37672806 P2860 Q37672806-0E68FC65-A1FA-41FD-9B28-2EB289D16457 @default.
- Q37672806 P2860 Q37672806-15E111BE-470B-4C68-A4DA-B51EE98392C8 @default.
- Q37672806 P2860 Q37672806-2CCDC77A-3D1F-4B7F-8253-2805C3336BCD @default.
- Q37672806 P2860 Q37672806-3E7871BC-74B1-4FA2-BF89-C558A9FB29CA @default.
- Q37672806 P2860 Q37672806-400F02EE-33A0-426E-BD01-0A3766586D2A @default.
- Q37672806 P2860 Q37672806-594DEC79-7191-4EB6-8205-5B091C87180C @default.
- Q37672806 P2860 Q37672806-594E6726-34C9-4793-8EF4-DC080B68EFB8 @default.
- Q37672806 P2860 Q37672806-5F134E9E-3824-42F5-A8A0-6852BB38CB80 @default.
- Q37672806 P2860 Q37672806-648737E7-91EC-4809-BBD5-EED5101D1EDC @default.
- Q37672806 P2860 Q37672806-6B4C52E1-47C9-4730-8FBF-403806464F04 @default.
- Q37672806 P2860 Q37672806-6B8B8027-C7D2-4541-B454-BC7C84B83B64 @default.
- Q37672806 P2860 Q37672806-6BA46EDF-F6ED-45C2-B2A5-BB7E88B18CBB @default.
- Q37672806 P2860 Q37672806-6E0608E7-83AF-476E-B972-FFF3C7467FA3 @default.
- Q37672806 P2860 Q37672806-8F3D7753-35C9-4674-928C-7216E26E901B @default.
- Q37672806 P2860 Q37672806-A4B975DE-642A-44AC-9A67-1024E9C32A75 @default.
- Q37672806 P2860 Q37672806-A9E16BEA-7B7C-410A-9EA7-08CA3CFCC3C0 @default.
- Q37672806 P2860 Q37672806-B3C2E2AF-AE3E-47F5-B382-1B78E50EA0B2 @default.
- Q37672806 P2860 Q37672806-C5C7686B-B791-4C6E-AFB8-022BF4154062 @default.
- Q37672806 P2860 Q37672806-D1409664-9F9A-4A84-98FE-64BFF9D8210D @default.
- Q37672806 P2860 Q37672806-ECE67DCE-8C7C-47D7-B5B6-DE0833743A0A @default.
- Q37672806 P2860 Q37672806-EFBE93E5-B3EE-407E-8BF0-68157F92FA2E @default.
- Q37672806 P2860 Q37672806-F595F3F5-11BB-4D5E-9AB2-53DDC7324439 @default.
- Q37672806 P2860 Q37672806-FCF7FCD0-A97B-48A7-9965-A3F3BA63C2AF @default.
- Q37672806 P304 Q37672806-EC92F8C4-0148-4BD9-A1E8-24EA42DA3945 @default.
- Q37672806 P31 Q37672806-CB8A378E-4B3D-4F94-A56F-0A8204CBF677 @default.
- Q37672806 P356 Q37672806-EBF5A84C-4742-4665-B924-8669BFFF4324 @default.
- Q37672806 P433 Q37672806-3A42B8E2-92C7-453B-A3DE-148ACFEC44E7 @default.
- Q37672806 P478 Q37672806-25CC9677-9992-4D2B-AF24-2245AB840033 @default.
- Q37672806 P50 Q37672806-02F380AF-F49E-455F-8AB9-50BD3FFA6344 @default.
- Q37672806 P577 Q37672806-9601BE2A-8977-497E-991F-74CAE709AE95 @default.
- Q37672806 P5875 Q37672806-5D441B34-85F2-4141-9DDF-3F359B055B52 @default.
- Q37672806 P698 Q37672806-4FB0DA81-2019-4436-8372-D376FF0B20FF @default.
- Q37672806 P921 Q37672806-23B225C1-1CEB-4380-85C3-34A9D6530C27 @default.
- Q37672806 P921 Q37672806-3ED2C011-BD1F-4F27-A7A5-928A9B79E574 @default.
- Q37672806 P921 Q37672806-55DEDE68-1BA5-43E6-A0B0-1F0EACBF6E54 @default.
- Q37672806 P921 Q37672806-5AE1BAD8-D36B-42F6-82BE-60B6603FDD70 @default.
- Q37672806 P921 Q37672806-9A27FC43-FCF4-494F-9DA3-FB61C614E984 @default.
- Q37672806 P932 Q37672806-48709072-6A43-485F-BD6C-6C0CCFA7A51C @default.
- Q37672806 P356 J.CURTHERES.2008.02.007 @default.
- Q37672806 P698 24692786 @default.
- Q37672806 P1433 Q15752574 @default.
- Q37672806 P1476 "Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study" @default.
- Q37672806 P2093 "Achara Chaovavanich" @default.
- Q37672806 P2093 "Chatiya Athichathanabadi" @default.
- Q37672806 P2093 "Sirirat Likanonsakul" @default.
- Q37672806 P2093 "Somsit Tansuphaswadikul" @default.
- Q37672806 P2093 "Weerawat Manosuthi" @default.
- Q37672806 P2093 "Wisit Prasithsirikul" @default.
- Q37672806 P2860 Q28367493 @default.
- Q37672806 P2860 Q31704898 @default.
- Q37672806 P2860 Q34350708 @default.
- Q37672806 P2860 Q35689833 @default.
- Q37672806 P2860 Q39021303 @default.
- Q37672806 P2860 Q39473036 @default.
- Q37672806 P2860 Q39525270 @default.
- Q37672806 P2860 Q41694988 @default.
- Q37672806 P2860 Q44198482 @default.
- Q37672806 P2860 Q44365647 @default.
- Q37672806 P2860 Q44486385 @default.
- Q37672806 P2860 Q44849439 @default.
- Q37672806 P2860 Q44997968 @default.
- Q37672806 P2860 Q45023725 @default.
- Q37672806 P2860 Q45134803 @default.
- Q37672806 P2860 Q45751686 @default.
- Q37672806 P2860 Q46898474 @default.
- Q37672806 P2860 Q47298369 @default.